➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Colorcon
McKinsey
Moodys
Dow

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Alprostadil - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for alprostadil
Recent Clinical Trials for alprostadil

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityEarly Phase 1
Assiut UniversityPhase 4
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2

See all alprostadil clinical trials

Medical Subject Heading (MeSH) Categories for alprostadil

US Patents and Regulatory Information for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-006 Jul 30, 1998 RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 DISCN Yes No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-003 Nov 19, 1996 RX Yes Yes   Start Trial   Start Trial   Start Trial
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-003 Oct 1, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa ALPROSTADIL alprostadil INJECTABLE;INJECTION 075196-001 Apr 30, 1999 AP RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 AP RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996   Start Trial   Start Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002   Start Trial   Start Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-004 May 19, 1997   Start Trial   Start Trial
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-002 Nov 19, 1996   Start Trial   Start Trial
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-003 Nov 19, 1996   Start Trial   Start Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
Dow
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.